These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9619817)

  • 1. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
    Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M
    AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
    Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
    Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.
    Brew BJ; Pemberton L; Blennow K; Wallin A; Hagberg L
    Neurology; 2005 Nov; 65(9):1490-2. PubMed ID: 16275845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral load in HIV-associated dementia.
    Glass JD; Wesselingh SL
    Ann Neurol; 1998 Jul; 44(1):150-1. PubMed ID: 9667609
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
    Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
    Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.
    Letendre SL; Lanier ER; McCutchan JA
    J Infect Dis; 1999 Aug; 180(2):310-9. PubMed ID: 10395844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
    Enting RH; Prins JM; Jurriaans S; Brinkman K; Portegies P; Lange JM
    Clin Infect Dis; 2001 Apr; 32(7):1095-9. PubMed ID: 11264039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?
    Perrella O; Carreiri PB; Perrella A; Sbreglia C; Gorga F; Guarnaccia D; Tarantino G
    Eur Cytokine Netw; 2001 Mar; 12(1):51-5. PubMed ID: 11282546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF, plasma viral load and HIV associated dementia.
    Robertson K; Fiscus S; Kapoor C; Robertson W; Schneider G; Shepard R; Howe L; Silva S; Hall C
    J Neurovirol; 1998 Feb; 4(1):90-4. PubMed ID: 9531015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
    Gisslen M; Hagberg L; Brew BJ; Cinque P; Price RW; Rosengren L
    J Infect Dis; 2007 Jun; 195(12):1774-8. PubMed ID: 17492593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid HIV load in diverse clinical circumstances.
    Jenny-Avital ER; Hoffman J; Katz M; Leider J; Apfelroth S
    Clin Infect Dis; 2008 Jun; 46(12):1938-40; author reply 1940-1. PubMed ID: 18540816
    [No Abstract]   [Full Text] [Related]  

  • 14. Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system.
    Delforge ML; Farber CM; De Leener F; Caroyer JM; Liesnard C; Van Vooren JP
    Clin Infect Dis; 1999 Apr; 28(4):931. PubMed ID: 10825078
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
    Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
    Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
    Tambussi G; Gori A; Capiluppi B; Balotta C; Papagno L; Morandini B; Di Pietro M; Ciuffreda D; Saracco A; Lazzarin A
    Clin Infect Dis; 2000 Jun; 30(6):962-5. PubMed ID: 10880317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSF) using amplicor HIV-1 monitor test.
    Honderlick P; Zucman D; Couderc LJ
    Pathol Biol (Paris); 1999 May; 47(5):560-2. PubMed ID: 10418040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
    Valle M; Price RW; Nilsson A; Heyes M; Verotta D
    Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological efficacy of stavudine, zidovudine, and lamivudine.
    Brew BJ
    Lancet; 1998 Aug; 352(9125):402. PubMed ID: 9717950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.